The BURROUGHS WELLCOME FUND is an independent private foundation dedicated to advancing the medical sciences by supporting research and other scientific and educational activities. It conducts a majority of its grant-making through competitive programs designed to support the career development of young scientists and to build capacity in research areas the fund believes to be undervalued or in need of targeted support. The fund’s board of directors is composed of distinguished scientists and business leaders, and the fund has, for several decades, been a leader in supporting medical research and training programs. Every year, the fund awards millions of dollars to universities, research centers, and foundations.
Wellcome Professorship in Clinical Pharmacology
School of Medicine
Clinical Pharmacology
Established in 1971 by the Burroughs Wellcome Fund
Held by Craig W. Hendrix
CRAIG W. HENDRIX, Osler Housestaff (1984-1986), Infectious Diseases & Clinical Pharmacology Fellow (1986-1989), the Wellcome Professor of Clinical Pharmacology, is Director of the Division of Clinical Pharmacology, and Professor of Medicine, Pharmacology and Molecular Sciences, and Epidemiology. His research is focused on the development of drugs for HIV prevention. His research contributed significantly to the demonstrated efficacy of tenofovir/emtricitabine and dapivirine for HIV pre-exposure prophylaxis. Dr. Hendrix has served on expert committees for the UN Department of Peace-Keeping Operations, the U.S. Food and Drug Administration, the Centers for Disease Control, and the National Academy of Medicine.
Among his honors are the Meritorious Service Medal (US Air Force), Johns Hopkins Alumni Association Excellence in Teaching Award, David M. Levine Faculty Mentoring Award, and the PhRMA Foundation Award in Excellence.